Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide) - Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL.
Summary
- From July 2023, Voxzogo co-packs will contain new solvent needles and new administration syringes due to supply chain reasons.
- The new solvent needle has an alternative safety mechanism with an activated safety shield cover (see Table 1).
- The new administration syringe has Units (U) graduation markings( typically used for insulin products and sometimes referred to as Insulin Units) instead of mL graduation markings (see Table 1).
- It is important that you explain to your patient or the caregiver the recommended dose to be delivered with the new syringe, as the units of measure are not 1:1. For example, 0.1 mL is equivalent to 10 U. Please see Table 2 for the conversion of single dose volumes from mL to U.
- There are no changes to the Voxzogo dosage or volume. Recommendations for use remain unchanged.
- The product information has been amended to reflect the use of new needles and syringes.
Published on: 04 September 2023
Una legislazione farmaceutica moderna è fondamentale per accompagnare l'#innovazione e garantire ai ...
Vai al post →
Si conclude la campagna #MedSafetyWeek di quest’anno! 🎉
Grazie per aver seguito i nostri canali in...
Vai al post →
Se sei un professionista sanitario, cogli l’occasione per discutere e individuare gli effetti indesi...
Vai al post →
💬 Ti è mai capitato di pensare “è solo un’eruzione cutanea”, “sono soltanto stressato” o “probabilm...
Vai al post →
Esistono diversi tipi di effetti indesiderati dei #farmaci: il modo in cui si manifestano può dipend...
Vai al post →
📍 A Roma la seconda edizione del Policy & Business Forum del Gruppo Editoriale @urania.news, import...
Vai al post →
